PROCEPT BioRobotics Corporation
PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinaā¦ read more
Healthcare
Medical Devices
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$18.62
Price+3.45%
$0.62
1Y
Price
Market Cap
$1.060b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-23.7%
EBITDA Margin-25.7%
Net Profit Margin-11.4%
Free Cash Flow Margin-23.7%
EBITDA Margin-25.7%
Net Profit Margin-11.4%
Free Cash Flow MarginRevenue
$322.024m
+33.6%
1y CAGR+60.0%
3y CAGR+74.4%
5y CAGREarnings
-$102.472m
+7.5%
1y CAGR-0.1%
3y CAGR-11.5%
5y CAGREPS
-$1.82
+12.6%
1y CAGR+6.7%
3y CAGR+16.5%
5y CAGRBook Value
$347.667m
$487.062m
Assets$139.395m
Liabilities$51.664m
DebtDebt to Assets
10.6%
-1x
Debt to EBITDAFree Cash Flow
-$80.566m
+23.1%
1y CAGR-5.0%
3y CAGR-14.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company